布鲁顿的氨酸激酶抑制剂具有不同的结合模式,揭示了对B细胞受体信号传递的不同功能影响
Wei Li1, Renata Sano1, Mutiah Apatira1
1Oncology Discovery, AbbVie Inc., South San Francisco, California.
Molecular cancer therapeutics
|September 21, 2023
概括
不同的布鲁顿.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 布鲁顿氨酸激酶 (BTK) 的小分子抑制剂已被批准用于B细胞恶性瘤,并对自身免疫性疾病进行研究.
- BTK 抑制剂 (BTKi) 的强度,选择性和结合方式各不相同 (背口袋,H3口袋,只有链).
研究的目的:
- 研究不同BTKi结合模式对B细胞受体 (BCR) 信号传导的影响.
- 为了评估BTKi活动的体外和体外B细胞淋巴瘤模型.
主要方法:
- 评估了BTK自化和PLCγ2转化抑制.
- 在BCR激活时测量了BTK介导的调动和PLCγ2激活.
- 利用RAC2缺陷的TMD8细胞来探索绕道机制.
主要成果:
- 所有的BTKi类型都抑制了BTK和PLCγ2酸化.
- 只有链的结合剂在抑制调动和PLCγ2激活方面效果较差.
- 当BTK仅受链抑制时,RAC2起到绕道作用,使剩余BCR信号成为可能.
结论:
- 在BCR信号传输中,BTK具有酶活性独立的功能,其中包括RAC2.
- 机械洞察力支持根据BTKi结合模式选择B细胞淋巴瘤的临床候选者.
更多相关视频
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
8.0K
09:40Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
Published on: September 28, 2018
15.2K
相关概念视频
Receptor Tyrosine Kinases
13.1K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
13.1K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Diversity of Antigen Receptors
620
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
620
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
